Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
allergan
biotech
boston blog main
boston top stories
2
×
clinical trials
eli lilly
fda
life sciences
national blog main
national top stories
10x genomics
alkermes
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
buprenorphine
cadent therapeutics
cariprazine
celgene
centers for disease control and prevention
chinook therapeutics
clostridium difficile
community-acquired bacterial pneumonia
dana hilt
daprodustat
david chacko
david marek
detroit blog main
detroit top stories
duchenne muscular dystrophy
What
fda
won
alkermes
antipsychotic
august
benefits
bio
biotech
busy
caveats
commonly
days
decisions
designed
devices
drug
drugs
effect
favor
gain
legacy
medicine
news
nods
offer
opioid
panel
past
prescribed
psyche
regulatory
roundup
sarepta’s
seven
shkreli’s
slow
stumble
suits
tends
treatment
Language
unset
Current search:
won���t
×
abbvie
×
" boston top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More